MetaCap

Enovis (ENOV) vs Polaris (PII)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Polaris (PII) has outperformed Enovis (ENOV) over the past year, gaining 0.2% versus a loss of 11.5%. Over five years, PII leads with a -46.6% price change compared with -69.5% for ENOV. Polaris is the larger company by market cap ($3.63 billion vs $1.47 billion), about 2.5 times the size, while Enovis is growing revenue faster (+6.7% vs -0.3%).

On valuation, Enovis trades at a lower forward P/E (7.4x vs 20.4x for Polaris). Polaris pays a dividend yielding 4.25%, while Enovis does not currently pay one. Polaris converts more of its revenue into profit, with a net margin of -6.5% versus -52.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ENOV-11.47%PII+0.19%
+20%-11%-42%
Nov 21, 20251 yearNov 20, 2026
ENOV-70.68%PII-46.76%
+17%-34%-84%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ENOV versus PII key metrics
MetricENOVPII
Share price$25.47$63.73
Market cap$1.47B$3.63B
1-day change-2.90%-1.12%
YTD return-4.39%+0.76%
1-year return-11.47%+0.19%
5-year return-69.49%-46.60%
Forward P/E7.3520.36
EPS (TTM)$-9.23$-3.67
Dividend yield0.00%4.25%
Annual dividend$0.00$2.71
Revenue (latest FY)$2.25B$7.15B
Revenue growth (YoY)+6.66%-0.33%
Net income (latest FY)$-1.18B$-465.50M
Gross margin59.84%19.14%
Operating margin-50.01%-4.88%
Net margin-52.69%-6.51%
52-week high$31.67$77.98
52-week low$16.70$47.14
Distance from 52-week high-19.58%-18.27%
Analyst consensusstrong_buynone
Avg. price target upside+48.53%+1.88%
Average volume1.71M828.69K
Shares outstanding57.69M56.93M
Employees7,80214,500
SectorHealth CareConsumer Discretionary
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Polaris is about 2.5 times larger than Enovis by market value ($3.63B vs $1.47B).
  • PII has outperformed ENOV by 11.7 percentage points over the past year.
  • Polaris offers a meaningfully higher dividend yield (4.25% vs 0.00%).
  • Polaris is more profitable, keeping -6.5 cents of every revenue dollar as net income versus -52.7 cents for Enovis.
  • Enovis grew revenue faster in its latest fiscal year (+6.66% vs -0.33%).
  • The two companies sit in different sectors: Enovis in Health Care and Polaris in Consumer Discretionary.

About Enovis

ENOV stock →

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.

Health Care · Industrial Specialties · 7,802 employees

About Polaris

PII stock →

Polaris Inc. designs, engineers, manufactures, and markets powersports vehicles in the United States, Canada, and internationally.

Consumer Discretionary · Industrial Specialties · 14,500 employees

ENOV vs PII FAQ

Which is bigger, Enovis or Polaris?

Polaris (PII) is larger, with a market capitalization of $3.63B compared with $1.47B for Enovis (ENOV).

Which stock has performed better over the past year, ENOV or PII?

PII returned +0.19% over the past 12 months, compared with -11.47% for ENOV (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Enovis or Polaris?

Polaris pays a dividend yielding 4.25%, while Enovis does not currently pay a regular dividend.

Are Enovis and Polaris in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons